Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.
Identifieur interne : 000883 ( Main/Exploration ); précédent : 000882; suivant : 000884Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.
Auteurs : Linda Dodds [Canada] ; Shelly A. Mcneil ; Deshayne B. Fell ; Victoria M. Allen ; Ann Coombs ; Jeffrey Scott ; Noni MacdonaldSource :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [ 1488-2329 ] ; 2007.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Appréciation des risques (MeSH), Comorbidité (MeSH), Complications infectieuses de la grossesse (diagnostic), Complications infectieuses de la grossesse (épidémiologie), Consultation médicale (statistiques et données numériques), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Grossesse (MeSH), Hospitalisation (statistiques et données numériques), Humains (MeSH), Incidence (MeSH), Intervalles de confiance (MeSH), Issue de la grossesse (MeSH), Loi de Poisson (MeSH), Maladies de l'appareil respiratoire (prévention et contrôle), Maladies de l'appareil respiratoire (épidémiologie), Nouvelle-Écosse (épidémiologie), Trimestres de grossesse (MeSH), Vaccination (normes), Vaccins antigrippaux (administration et posologie), Valeurs de référence (MeSH), Études de cohortes (MeSH), Études rétrospectives (MeSH).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- diagnostic : Complications infectieuses de la grossesse.
- normes : Vaccination.
- prévention et contrôle : Grippe humaine, Maladies de l'appareil respiratoire.
- statistiques et données numériques : Consultation médicale, Hospitalisation.
- épidémiologie : Complications infectieuses de la grossesse, Grippe humaine, Maladies de l'appareil respiratoire, Nouvelle-Écosse.
- Adulte, Appréciation des risques, Comorbidité, Femelle, Grossesse, Humains, Incidence, Intervalles de confiance, Issue de la grossesse, Loi de Poisson, Trimestres de grossesse, Valeurs de référence, Études de cohortes, Études rétrospectives.
English descriptors
- KwdEn :
- Adult (MeSH), Cohort Studies (MeSH), Comorbidity (MeSH), Confidence Intervals (MeSH), Female (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Incidence (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Nova Scotia (epidemiology), Office Visits (statistics & numerical data), Poisson Distribution (MeSH), Pregnancy (MeSH), Pregnancy Complications, Infectious (diagnosis), Pregnancy Complications, Infectious (epidemiology), Pregnancy Outcome (MeSH), Pregnancy Trimesters (MeSH), Reference Values (MeSH), Respiratory Tract Diseases (epidemiology), Respiratory Tract Diseases (prevention & control), Retrospective Studies (MeSH), Risk Assessment (MeSH), Vaccination (standards).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Nova Scotia.
- diagnosis : Pregnancy Complications, Infectious.
- epidemiology : Influenza, Human, Pregnancy Complications, Infectious, Respiratory Tract Diseases.
- prevention & control : Influenza, Human, Respiratory Tract Diseases.
- standards : Vaccination.
- statistics & numerical data : Hospitalization, Office Visits.
- Adult, Cohort Studies, Comorbidity, Confidence Intervals, Female, Humans, Incidence, Poisson Distribution, Pregnancy, Pregnancy Outcome, Pregnancy Trimesters, Reference Values, Retrospective Studies, Risk Assessment.
Abstract
BACKGROUND
Excess deaths have occurred among pregnant women during influenza pandemics, but the impact of influenza during nonpandemic years is unclear. We evaluated the impact of exposure during nonpandemic influenza seasons on the rates of hospital admissions and physician visits because of respiratory illness among pregnant women.
METHODS
We conducted a 13-year (1990-2002) population-based cohort study involving pregnant women in Nova Scotia. We compared rates of hospital admissions and physician office visits because of respiratory illness during the influenza season in each trimester of pregnancy with rates during the influenza season in the year before pregnancy and with rates in non-influenza seasons. Poisson regression analyses were performed to estimate rate ratios and 95% confidence intervals (CIs).
RESULTS
Of 134,188 pregnant women in the study cohort, 510 (0.4%) were admitted to hospital because of a respiratory illness during pregnancy and 33,775 (25.2%) visited their physician for the same reason during pregnancy. During the influenza seasons, the rate ratio of hospital admissions in the third trimester compared with admissions in the year before pregnancy was 7.9 (95% CI 5.0-12.5) among women with comorbidities and 5.1 (95% CI 3.6-7.3) among those without comorbidities. The rate of hospital admissions in the third trimester among women without comorbidities was 7.4 per 10,000 woman-months during the influenza season, compared with 5.4 and 3.1 per 10,000 woman-months during the peri-and non-influenza seasons respectively. Corresponding rates among women with comorbidities were 44.9, 9.3 and 18.9 per 10,000 woman-months. Only 6.7% of women with comorbidities had received influenza immunization.
INTERPRETATION
Our data support the recommendation that pregnant women with comorbidities should receive influenza vaccination regardless of their stage of pregnancy during the influenza season. Since hospital admissions because of respiratory illness during the influenza season were also increased among pregnant women without comorbidities, all pregnant women are likely to benefit from influenza vaccination.
DOI: 10.1503/cmaj.061435
PubMed: 17296958
PubMed Central: PMC1800555
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.</title><author><name sortKey="Dodds, Linda" sort="Dodds, Linda" uniqKey="Dodds L" first="Linda" last="Dodds">Linda Dodds</name><affiliation wicri:level="1"><nlm:affiliation>Canadian Centre for Vaccinology, Halifax, NS. l.dodds@dal.ca</nlm:affiliation><country wicri:rule="url">Canada</country></affiliation></author><author><name sortKey="Mcneil, Shelly A" sort="Mcneil, Shelly A" uniqKey="Mcneil S" first="Shelly A" last="Mcneil">Shelly A. Mcneil</name></author><author><name sortKey="Fell, Deshayne B" sort="Fell, Deshayne B" uniqKey="Fell D" first="Deshayne B" last="Fell">Deshayne B. Fell</name></author><author><name sortKey="Allen, Victoria M" sort="Allen, Victoria M" uniqKey="Allen V" first="Victoria M" last="Allen">Victoria M. Allen</name></author><author><name sortKey="Coombs, Ann" sort="Coombs, Ann" uniqKey="Coombs A" first="Ann" last="Coombs">Ann Coombs</name></author><author><name sortKey="Scott, Jeffrey" sort="Scott, Jeffrey" uniqKey="Scott J" first="Jeffrey" last="Scott">Jeffrey Scott</name></author><author><name sortKey="Macdonald, Noni" sort="Macdonald, Noni" uniqKey="Macdonald N" first="Noni" last="Macdonald">Noni Macdonald</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17296958</idno><idno type="pmid">17296958</idno><idno type="doi">10.1503/cmaj.061435</idno><idno type="pmc">PMC1800555</idno><idno type="wicri:Area/Main/Corpus">000890</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000890</idno><idno type="wicri:Area/Main/Curation">000890</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000890</idno><idno type="wicri:Area/Main/Exploration">000890</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.</title><author><name sortKey="Dodds, Linda" sort="Dodds, Linda" uniqKey="Dodds L" first="Linda" last="Dodds">Linda Dodds</name><affiliation wicri:level="1"><nlm:affiliation>Canadian Centre for Vaccinology, Halifax, NS. l.dodds@dal.ca</nlm:affiliation><country wicri:rule="url">Canada</country></affiliation></author><author><name sortKey="Mcneil, Shelly A" sort="Mcneil, Shelly A" uniqKey="Mcneil S" first="Shelly A" last="Mcneil">Shelly A. Mcneil</name></author><author><name sortKey="Fell, Deshayne B" sort="Fell, Deshayne B" uniqKey="Fell D" first="Deshayne B" last="Fell">Deshayne B. Fell</name></author><author><name sortKey="Allen, Victoria M" sort="Allen, Victoria M" uniqKey="Allen V" first="Victoria M" last="Allen">Victoria M. Allen</name></author><author><name sortKey="Coombs, Ann" sort="Coombs, Ann" uniqKey="Coombs A" first="Ann" last="Coombs">Ann Coombs</name></author><author><name sortKey="Scott, Jeffrey" sort="Scott, Jeffrey" uniqKey="Scott J" first="Jeffrey" last="Scott">Jeffrey Scott</name></author><author><name sortKey="Macdonald, Noni" sort="Macdonald, Noni" uniqKey="Macdonald N" first="Noni" last="Macdonald">Noni Macdonald</name></author></analytic><series><title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title><idno type="eISSN">1488-2329</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Cohort Studies (MeSH)</term><term>Comorbidity (MeSH)</term><term>Confidence Intervals (MeSH)</term><term>Female (MeSH)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Nova Scotia (epidemiology)</term><term>Office Visits (statistics & numerical data)</term><term>Poisson Distribution (MeSH)</term><term>Pregnancy (MeSH)</term><term>Pregnancy Complications, Infectious (diagnosis)</term><term>Pregnancy Complications, Infectious (epidemiology)</term><term>Pregnancy Outcome (MeSH)</term><term>Pregnancy Trimesters (MeSH)</term><term>Reference Values (MeSH)</term><term>Respiratory Tract Diseases (epidemiology)</term><term>Respiratory Tract Diseases (prevention & control)</term><term>Retrospective Studies (MeSH)</term><term>Risk Assessment (MeSH)</term><term>Vaccination (standards)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Appréciation des risques (MeSH)</term><term>Comorbidité (MeSH)</term><term>Complications infectieuses de la grossesse (diagnostic)</term><term>Complications infectieuses de la grossesse (épidémiologie)</term><term>Consultation médicale (statistiques et données numériques)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Grossesse (MeSH)</term><term>Hospitalisation (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Intervalles de confiance (MeSH)</term><term>Issue de la grossesse (MeSH)</term><term>Loi de Poisson (MeSH)</term><term>Maladies de l'appareil respiratoire (prévention et contrôle)</term><term>Maladies de l'appareil respiratoire (épidémiologie)</term><term>Nouvelle-Écosse (épidémiologie)</term><term>Trimestres de grossesse (MeSH)</term><term>Vaccination (normes)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Valeurs de référence (MeSH)</term><term>Études de cohortes (MeSH)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Nova Scotia</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Complications infectieuses de la grossesse</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term><term>Respiratory Tract Diseases</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Respiratory Tract Diseases</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term><term>Maladies de l'appareil respiratoire</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term><term>Office Visits</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Consultation médicale</term><term>Hospitalisation</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Grippe humaine</term><term>Maladies de l'appareil respiratoire</term><term>Nouvelle-Écosse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cohort Studies</term><term>Comorbidity</term><term>Confidence Intervals</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Poisson Distribution</term><term>Pregnancy</term><term>Pregnancy Outcome</term><term>Pregnancy Trimesters</term><term>Reference Values</term><term>Retrospective Studies</term><term>Risk Assessment</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Appréciation des risques</term><term>Comorbidité</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Incidence</term><term>Intervalles de confiance</term><term>Issue de la grossesse</term><term>Loi de Poisson</term><term>Trimestres de grossesse</term><term>Valeurs de référence</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Excess deaths have occurred among pregnant women during influenza pandemics, but the impact of influenza during nonpandemic years is unclear. We evaluated the impact of exposure during nonpandemic influenza seasons on the rates of hospital admissions and physician visits because of respiratory illness among pregnant women.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We conducted a 13-year (1990-2002) population-based cohort study involving pregnant women in Nova Scotia. We compared rates of hospital admissions and physician office visits because of respiratory illness during the influenza season in each trimester of pregnancy with rates during the influenza season in the year before pregnancy and with rates in non-influenza seasons. Poisson regression analyses were performed to estimate rate ratios and 95% confidence intervals (CIs).</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Of 134,188 pregnant women in the study cohort, 510 (0.4%) were admitted to hospital because of a respiratory illness during pregnancy and 33,775 (25.2%) visited their physician for the same reason during pregnancy. During the influenza seasons, the rate ratio of hospital admissions in the third trimester compared with admissions in the year before pregnancy was 7.9 (95% CI 5.0-12.5) among women with comorbidities and 5.1 (95% CI 3.6-7.3) among those without comorbidities. The rate of hospital admissions in the third trimester among women without comorbidities was 7.4 per 10,000 woman-months during the influenza season, compared with 5.4 and 3.1 per 10,000 woman-months during the peri-and non-influenza seasons respectively. Corresponding rates among women with comorbidities were 44.9, 9.3 and 18.9 per 10,000 woman-months. Only 6.7% of women with comorbidities had received influenza immunization.</p></div><div type="abstract" xml:lang="en"><p><b>INTERPRETATION</b></p><p>Our data support the recommendation that pregnant women with comorbidities should receive influenza vaccination regardless of their stage of pregnancy during the influenza season. Since hospital admissions because of respiratory illness during the influenza season were also increased among pregnant women without comorbidities, all pregnant women are likely to benefit from influenza vaccination.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17296958</PMID><DateCompleted><Year>2007</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1488-2329</ISSN><JournalIssue CitedMedium="Internet"><Volume>176</Volume><Issue>4</Issue><PubDate><Year>2007</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title><ISOAbbreviation>CMAJ</ISOAbbreviation></Journal><ArticleTitle>Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.</ArticleTitle><Pagination><MedlinePgn>463-8</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Excess deaths have occurred among pregnant women during influenza pandemics, but the impact of influenza during nonpandemic years is unclear. We evaluated the impact of exposure during nonpandemic influenza seasons on the rates of hospital admissions and physician visits because of respiratory illness among pregnant women.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a 13-year (1990-2002) population-based cohort study involving pregnant women in Nova Scotia. We compared rates of hospital admissions and physician office visits because of respiratory illness during the influenza season in each trimester of pregnancy with rates during the influenza season in the year before pregnancy and with rates in non-influenza seasons. Poisson regression analyses were performed to estimate rate ratios and 95% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 134,188 pregnant women in the study cohort, 510 (0.4%) were admitted to hospital because of a respiratory illness during pregnancy and 33,775 (25.2%) visited their physician for the same reason during pregnancy. During the influenza seasons, the rate ratio of hospital admissions in the third trimester compared with admissions in the year before pregnancy was 7.9 (95% CI 5.0-12.5) among women with comorbidities and 5.1 (95% CI 3.6-7.3) among those without comorbidities. The rate of hospital admissions in the third trimester among women without comorbidities was 7.4 per 10,000 woman-months during the influenza season, compared with 5.4 and 3.1 per 10,000 woman-months during the peri-and non-influenza seasons respectively. Corresponding rates among women with comorbidities were 44.9, 9.3 and 18.9 per 10,000 woman-months. Only 6.7% of women with comorbidities had received influenza immunization.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Our data support the recommendation that pregnant women with comorbidities should receive influenza vaccination regardless of their stage of pregnancy during the influenza season. Since hospital admissions because of respiratory illness during the influenza season were also increased among pregnant women without comorbidities, all pregnant women are likely to benefit from influenza vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dodds</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Canadian Centre for Vaccinology, Halifax, NS. l.dodds@dal.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNeil</LastName><ForeName>Shelly A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Fell</LastName><ForeName>Deshayne B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Victoria M</ForeName><Initials>VM</Initials></Author><Author ValidYN="Y"><LastName>Coombs</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Noni</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>CMAJ</MedlineTA><NlmUniqueID>9711805</NlmUniqueID><ISSNLinking>0820-3946</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009674" MajorTopicYN="N" Type="Geographic">Nova Scotia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009819" MajorTopicYN="N">Office Visits</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016012" MajorTopicYN="N">Poisson Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="Y">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011264" MajorTopicYN="N">Pregnancy Trimesters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>2</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>3</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>2</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17296958</ArticleId><ArticleId IdType="pii">176/4/463</ArticleId><ArticleId IdType="doi">10.1503/cmaj.061435</ArticleId><ArticleId IdType="pmc">PMC1800555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Public Health. 1998 Jul;88(7):1074-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9663157</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1993 Sep;168(3):647-56</Citation><ArticleIdList><ArticleId IdType="pubmed">8354906</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 1959 Dec;78:1172-5</Citation><ArticleIdList><ArticleId IdType="pubmed">13824729</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S188-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15577572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Obstet Gynaecol Can. 2004 Nov;26(11):961-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15605434</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2005 Apr;192(4):1098-106</Citation><ArticleIdList><ArticleId IdType="pubmed">15846187</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Methods Med Res. 2006 Apr;15(2):103-26</Citation><ArticleIdList><ArticleId IdType="pubmed">16615652</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1996 Apr 20;312(7037):999-1003</Citation><ArticleIdList><ArticleId IdType="pubmed">8616393</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):225-31</Citation><ArticleIdList><ArticleId IdType="pubmed">10648763</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1996 Apr 20;312(7037):1004-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8616345</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1996 Apr 20;312(7037):1013-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8616348</ArticleId></ArticleIdList></Reference><Reference><Citation>Popul Stud (Camb). 1982 Nov;36(3):441-58</Citation><ArticleIdList><ArticleId IdType="pubmed">11630829</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Jun 14;314(7096):1724-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9185498</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):232-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10648764</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2000 Apr 1;320(7239):898-902</Citation><ArticleIdList><ArticleId IdType="pubmed">10741994</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2002 Jan 15;185(2):147-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11807687</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2003 Dec;189(6):1705-12</Citation><ArticleIdList><ArticleId IdType="pubmed">14710102</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15163927</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 2004 Jun 15;30:1-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15239483</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Perinatol. 2004 Aug;21(6):333-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15311370</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Obstet Gynecol. 1979 Jun;22(2):293-300</Citation><ArticleIdList><ArticleId IdType="pubmed">466875</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1979 Aug;140(2):141-6</Citation><ArticleIdList><ArticleId IdType="pubmed">479636</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1979 Aug;10(2):184-7</Citation><ArticleIdList><ArticleId IdType="pubmed">583151</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1980 Dec;112(6):798-811</Citation><ArticleIdList><ArticleId IdType="pubmed">7457471</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 1981 Jun 1;140(3):240-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7246624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Infect Dis. 1983 Jul-Aug;5(4):723-36</Citation><ArticleIdList><ArticleId IdType="pubmed">6353529</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Perinatol. 1986 Jul;3(3):179-82</Citation><ArticleIdList><ArticleId IdType="pubmed">3718637</ArticleId></ArticleIdList></Reference><Reference><Citation>J Reprod Med. 1988 Apr;33(4):399-401</Citation><ArticleIdList><ArticleId IdType="pubmed">3367344</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1992 Jan 18;304(6820):165-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1637372</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1998 Dec 1;148(11):1094-102</Citation><ArticleIdList><ArticleId IdType="pubmed">9850132</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Allen, Victoria M" sort="Allen, Victoria M" uniqKey="Allen V" first="Victoria M" last="Allen">Victoria M. Allen</name><name sortKey="Coombs, Ann" sort="Coombs, Ann" uniqKey="Coombs A" first="Ann" last="Coombs">Ann Coombs</name><name sortKey="Fell, Deshayne B" sort="Fell, Deshayne B" uniqKey="Fell D" first="Deshayne B" last="Fell">Deshayne B. Fell</name><name sortKey="Macdonald, Noni" sort="Macdonald, Noni" uniqKey="Macdonald N" first="Noni" last="Macdonald">Noni Macdonald</name><name sortKey="Mcneil, Shelly A" sort="Mcneil, Shelly A" uniqKey="Mcneil S" first="Shelly A" last="Mcneil">Shelly A. Mcneil</name><name sortKey="Scott, Jeffrey" sort="Scott, Jeffrey" uniqKey="Scott J" first="Jeffrey" last="Scott">Jeffrey Scott</name></noCountry><country name="Canada"><noRegion><name sortKey="Dodds, Linda" sort="Dodds, Linda" uniqKey="Dodds L" first="Linda" last="Dodds">Linda Dodds</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000883 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000883 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeCanadaV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:17296958
|texte= Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17296958" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV4
| This area was generated with Dilib version V0.6.35. |  |